Australia

GENETIC SIGNATURES LIMITED (GSS)

Track

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Dr Nickolaos (Nick) Samaras Director
Transaction date
Purchase
Price
126.22
Quantity 32,326
Value A$4,098,215
Dr John Melki Director
Transaction date
Purchase
Price
381.25
Quantity 30,456
Value A$4,522,127
Dr Anthony Radford Director
Transaction date
Purchase
Price
190.48
Quantity 38,353
Value A$1,734,030
Ms Caroline Waldron Director
Transaction date
Purchase
Price
0.37
Quantity 2,512
Value A$929
Caroline Waldron Director
Transaction date
Purchase
Price
0.86
Quantity 16,700
Value A$14,314
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-25 2024-01-25 B Purchase Dr Nickolaos (Nick) Samaras Director
32,326
126.22
A$4,098,215 		32,326 126.22 A$4,098,215
2024-01-25 2024-01-25 B Purchase Dr John Melki Director
30,456
381.25
A$4,522,127 		30,456 381.25 A$4,522,127
2024-01-25 2024-01-25 B Purchase Dr Anthony Radford Director
38,353
190.48
A$1,734,030 		38,353 190.48 A$1,734,030
2024-01-25 2024-01-25 B Purchase Ms Caroline Waldron Director
2,512
0.37
A$929 		2,512 0.37 A$929
2023-03-01 2023-02-28 B Purchase Caroline Waldron Director
16,700
0.86
A$14,314 		16,700 0.86 A$14,314
Explore more

More insider trading research around GENETIC SIGNATURES LIMITED

More insider trades in Australia
Insider trading in Asia-Pacific